ATE439857T1 - Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen - Google Patents
Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionenInfo
- Publication number
- ATE439857T1 ATE439857T1 AT00914930T AT00914930T ATE439857T1 AT E439857 T1 ATE439857 T1 AT E439857T1 AT 00914930 T AT00914930 T AT 00914930T AT 00914930 T AT00914930 T AT 00914930T AT E439857 T1 ATE439857 T1 AT E439857T1
- Authority
- AT
- Austria
- Prior art keywords
- lipoglycan
- compositions
- methods
- parasitic infections
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Materials Engineering (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12393199P | 1999-03-12 | 1999-03-12 | |
PCT/US2000/006404 WO2000053220A1 (en) | 1999-03-12 | 2000-03-10 | Lipoglycan compositions and methods of treating parasitic infections |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE439857T1 true ATE439857T1 (de) | 2009-09-15 |
Family
ID=22411778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00914930T ATE439857T1 (de) | 1999-03-12 | 2000-03-10 | Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen |
Country Status (17)
Country | Link |
---|---|
US (3) | US6428793B1 (de) |
EP (1) | EP1175226B1 (de) |
JP (1) | JP2002538220A (de) |
AT (1) | ATE439857T1 (de) |
AU (1) | AU771373B2 (de) |
BR (1) | BR0008949A (de) |
CA (1) | CA2364507A1 (de) |
DE (1) | DE60042776D1 (de) |
HU (1) | HUP0200466A3 (de) |
MA (1) | MA25347A1 (de) |
MX (1) | MXPA01009206A (de) |
NO (1) | NO20014411L (de) |
NZ (1) | NZ514112A (de) |
PL (1) | PL203789B1 (de) |
TR (3) | TR200202078T2 (de) |
WO (1) | WO2000053220A1 (de) |
ZA (1) | ZA200107502B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
US7164520B2 (en) | 2004-05-12 | 2007-01-16 | Idc, Llc | Packaging for an interferometric modulator |
WO2006041613A2 (en) * | 2004-10-05 | 2006-04-20 | Nanomega Medical Corporation | Nanoparticles for targeting hepatoma cells |
EP2490707B1 (de) * | 2009-10-21 | 2016-07-27 | ETH Zurich | Medizinische nützlichkeit von glycanbindenden proteinen und glycanen |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2598147B1 (fr) * | 1986-04-30 | 1988-08-26 | Pasteur Institut | Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene. |
FR2601021B2 (fr) * | 1986-07-07 | 1988-11-18 | Pasteur Institut | Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant |
US5280113A (en) | 1989-08-16 | 1994-01-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
US5212298A (en) * | 1989-08-16 | 1993-05-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
US5679347A (en) | 1992-12-10 | 1997-10-21 | Brigham And Women's Hospital | Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods |
US5541075A (en) * | 1993-02-05 | 1996-07-30 | Heska Corporation | Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
BR9305075A (pt) * | 1993-12-16 | 1995-08-08 | Fundacao Oswaldo Cruz | Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico |
WO2000017654A1 (en) * | 1998-09-21 | 2000-03-30 | Cummings Richard D | Assays for helminth infections |
-
2000
- 2000-03-10 HU HU0200466A patent/HUP0200466A3/hu unknown
- 2000-03-10 TR TR2002/02078T patent/TR200202078T2/xx unknown
- 2000-03-10 BR BR0008949-4A patent/BR0008949A/pt not_active IP Right Cessation
- 2000-03-10 JP JP2000603709A patent/JP2002538220A/ja active Pending
- 2000-03-10 EP EP00914930A patent/EP1175226B1/de not_active Expired - Lifetime
- 2000-03-10 TR TR2002/02066T patent/TR200202066T2/xx unknown
- 2000-03-10 WO PCT/US2000/006404 patent/WO2000053220A1/en active IP Right Grant
- 2000-03-10 US US09/523,404 patent/US6428793B1/en not_active Expired - Lifetime
- 2000-03-10 CA CA002364507A patent/CA2364507A1/en not_active Abandoned
- 2000-03-10 TR TR2001/03231T patent/TR200103231T2/xx unknown
- 2000-03-10 AU AU36251/00A patent/AU771373B2/en not_active Ceased
- 2000-03-10 DE DE60042776T patent/DE60042776D1/de not_active Expired - Fee Related
- 2000-03-10 AT AT00914930T patent/ATE439857T1/de not_active IP Right Cessation
- 2000-03-10 NZ NZ514112A patent/NZ514112A/en not_active IP Right Cessation
- 2000-03-10 PL PL350989A patent/PL203789B1/pl not_active IP Right Cessation
- 2000-03-10 MX MXPA01009206A patent/MXPA01009206A/es active IP Right Grant
-
2001
- 2001-09-11 ZA ZA200107502A patent/ZA200107502B/xx unknown
- 2001-09-11 NO NO20014411A patent/NO20014411L/no not_active Application Discontinuation
- 2001-09-12 MA MA26327A patent/MA25347A1/fr unknown
-
2002
- 2002-06-17 US US10/174,130 patent/US7063848B2/en not_active Expired - Fee Related
-
2006
- 2006-04-27 US US11/412,773 patent/US7204983B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ514112A (en) | 2003-08-29 |
DE60042776D1 (de) | 2009-10-01 |
NO20014411D0 (no) | 2001-09-11 |
US7204983B2 (en) | 2007-04-17 |
PL203789B1 (pl) | 2009-11-30 |
MA25347A1 (fr) | 2001-12-31 |
US20060228382A1 (en) | 2006-10-12 |
US7063848B2 (en) | 2006-06-20 |
AU771373B2 (en) | 2004-03-18 |
CA2364507A1 (en) | 2000-09-14 |
EP1175226A1 (de) | 2002-01-30 |
HUP0200466A2 (en) | 2002-06-29 |
JP2002538220A (ja) | 2002-11-12 |
EP1175226A4 (de) | 2005-01-05 |
WO2000053220A1 (en) | 2000-09-14 |
AU3625100A (en) | 2000-09-28 |
ZA200107502B (en) | 2003-02-26 |
TR200202078T2 (tr) | 2002-11-21 |
PL350989A1 (en) | 2003-02-24 |
US6428793B1 (en) | 2002-08-06 |
US20020160021A1 (en) | 2002-10-31 |
TR200103231T2 (tr) | 2002-03-21 |
EP1175226B1 (de) | 2009-08-19 |
TR200202066T2 (tr) | 2004-12-21 |
HUP0200466A3 (en) | 2006-11-28 |
BR0008949A (pt) | 2002-09-24 |
NO20014411L (no) | 2001-11-09 |
MXPA01009206A (es) | 2003-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
GR3032037T3 (en) | Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them | |
DE69733611D1 (de) | Verfahren und potenzierte zusammensetzung zur behandlung von migräne | |
ES2137498T3 (es) | Inmunogenos contra la hormona liberadora de gonadotropinas. | |
NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
DK0729473T3 (da) | Glucosamin-disaccharider, fremgangsmåde til deres fremstilling farmaceutisk sammensætning deraf og deres anvendelse | |
DE69516540T2 (de) | AMINO-IMIDAZO [4,5-c] CHINOLINE | |
MX9301706A (es) | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. | |
PT692028E (pt) | Farmacos baseados em papilomavirus | |
MX9401225A (es) | Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion. | |
FI972703A (fi) | Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia | |
ES2182914T3 (es) | Inmunopotenciacion inducida de quitosan. | |
DE60331725D1 (de) | Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren | |
ATE439857T1 (de) | Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen | |
ES2157899T3 (es) | Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos. | |
WO2001039765A8 (en) | Compositions and methods for the induction and treatment of retinal detachments | |
DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
WO2000057908A3 (en) | Attenuated dengue-1 virus vaccine | |
NO992030L (no) | Terapeutiske og kosmetiske sammensetninger, deres anvendelse og fremgangsmÕte for fremstilling derav | |
EP1131338A4 (de) | Methode für die herstellung von gereinigtem invasinprotein und seine anwendung | |
DE69429521D1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
WO2003006645A3 (en) | Method and composition for inhibiting heparanase activity | |
DE60045516D1 (de) | Pflanzen lektine als mukosale adjuvantien | |
BR9507848A (pt) | Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol | |
IT1254452B (it) | N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |